PlainPharmaWatch

CMS Open Payments · Program Year 2024

New York

New York received $216,754,628.71 in pharmaceutical-industry payments to 49,928 physicians and 104 teaching hospitals across 1,060,599 transactions.

$216.8M
Total payments
$184.9M
To physicians
$17.0M
To teaching hospitals
#6
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $216.8M in payments to 49,928 physicians and 104 teaching hospitals in New York. That ranks New York #6 of 59 states and territories (1.6% of the US total), averaging $3.7K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

New York pairs top-10% payment volume with an overwhelmingly physician-directed payment mix.

#6
of 59 states
1.6%
of the national total
85.3%
to physicians vs. hospitals
49,928
physicians paid

What the Data Shows for New York

New York sits in the high-volume tercile at #6 of 59 by all-tracks dollars (1.6% of the US total): $216,754,628.71 across 1,060,599 PY2024 transactions.

The distinctive cut versus volume is the physician share: 85.3% of dollars to 49,928 physicians ($3.7K each). Average transaction $204.37. Leading nature of payment: "Compensation for Services Other Than Consulting" at $49.4M (22.8% of the state file; top-three natures 63.6%).

New York sits in the 92nd percentile (top-10 nationally). Just above: Texas ($224.7M). Just below: Missouri ($121.9M). For context: top-ranked California ($342.4M) is 1.6× larger than New York. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in New York are distributed between physicians and teaching hospitals.

Physician Payments

$184.9M

85.3% of total · 49,928 recipients · $3.7K avg

Teaching Hospital Payments

$17.0M

7.9% of total · 104 hospitals · $163.6K avg

Payment Breakdown by Type

New York has 16 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 22.8%.

Nature concentration in New York

Top three Open Payments natures are 63.6% of state dollars; residual is every other reported nature

Compensation for Services Ot…$49.4MConsulting Fee$49.1MRoyalty or License$39.4MAll other natures (13)$78.9M

Payment categories in New York

Top categories by total reported dollar volume

1. Compensation for Services…$49.4M2. Consulting Fee$49.1M3. Royalty or License$39.4M4. Food and Beverage$30.4M5. Travel and Lodging$15.2M6. Grant$10.2M7. Acquisitions$5.6M8. Honoraria$4.2M9. Education$3.4M10. Long-Term Medical Supply…$3.1M
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $49.4M 18,948
Consulting Fee $49.1M 14,944
Royalty or License $39.4M 1,091
Food and Beverage $30.4M 964,991
Travel and Lodging $15.2M 40,825
Grant $10.2M 832
Acquisitions $5.6M 38
Honoraria $4.2M 1,422
Education $3.4M 11,002
Long-Term Medical Supply or Device Loan $3.1M 2,133
Compensation for Faculty or Speaker (Medical Education) $2.5M 1,057
Debt Forgiveness $2.1M 608
Space Rental or Facility Fees $1.5M 435
Gift $319.3K 1,885
Charitable Contribution $279.4K 36
Entertainment $44.0K 352

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What New York totals can and cannot tell you

The aggregate payment figure for New York measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download New York's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.